Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.40 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 6/20 | 0.38 |
| ▸ | HPGD | P15428 | 6/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | CASP7 | P55210 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | AHR | P35869 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | EGFR | P00533 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29721611 | 1.00 | ALDH1A1 (0.47) | ALDH1A1KDM4ESMN1; SMN2LIMK1MAPT | |
| SCHEMBL22249796 | 0.82 | KDM4E (0.36) | ALDH1A1KDM4ESMN1; SMN2MAPTHPGD | |
| SCHEMBL24270376 | 0.81 | KDM4E (0.36) | ALDH1A1KDM4E | |
| SCHEMBL24270375 | 0.79 | IDO1 (0.40) | — | |
| SCHEMBL26423219 | 0.79 | EGFR (0.39) | ALDH1A1KDM4ESMN1; SMN2MAPTHPGD | |
| SCHEMBL24624020 | 0.79 | EGFR (0.31) | EGFR | |
| SCHEMBL25463798 | 0.78 | KDM4E (0.32) | ALDH1A1KDM4ESMN1; SMN2MAPTHPGD | |
| SCHEMBL19579027 | 0.78 | HCRTR1 (0.33) | ALDH1A1KDM4ESMN1; SMN2LIMK1MAPT | |
| SCHEMBL24270374 | 0.77 | KDM4E (0.43) | ALDH1A1KDM4EMAPTNPC1EGFR | |
| SCHEMBL24270377 | 0.77 | KDM4E (0.44) | ALDH1A1KDM4ESMN1; SMN2MAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 314 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637400-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2026-05-26 | — | — | US | disclosed |
| US-20260143922-A1 | ORGANIC LIGHT EMITTING DISPLAY AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2026-05-21 | — | — | US | disclosed |
| EP-4746654-A1 | ORGANIC LIGHT EMITTING DISPLAY AND ELECTRONIC DEVICE THEREOF | Duk San Neolux Co., Ltd. (KR) | 2026-05-20 | — | — | EP | disclosed |
| US-20260130109-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2026-05-07 | — | — | US | disclosed |
| US-20260123185-A1 | PIXEL DEFINE LAYER | DUK SAN NEOLUX CO., LTD. (KR) | 2026-04-30 | — | — | US | disclosed |
| US-20260123184-A1 | PIXEL DEFINE LAYER | DUK SAN NEOLUX CO., LTD. (KR) | 2026-04-30 | — | — | US | disclosed |
| US-20260123278-A1 | COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2026-04-30 | — | — | US | disclosed |
| US-12610737-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2026-04-21 | — | — | US | disclosed |
| US-20260107626-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2026-04-16 | — | — | US | disclosed |
| EP-4727310-A1 | ORGANIC ELECTRIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRIC ELEMENT, AND ELECTRONIC DEVICE THEREFOR | Duk San Neolux Co., Ltd. (KR) | 2026-04-15 | — | — | EP | disclosed |
| WO-2017186760-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2017-11-02 | — | — | WO | disclosed |
| US-9755159-B2 | Organic materials for OLEDs | UNIVERSAL DISPLAY CORPORATION (US) | 2017-09-05 | — | — | US | disclosed |
| US-9755159-B2 | Organic materials for OLEDs | UNIVERSAL DISPLAY CORPORATION (US) | 2017-09-05 | — | — | US | disclosed |
| US-20160329502-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2016-11-10 | — | — | US | disclosed |
| US-9184399-B2 | Asymmetric hosts with triaryl silane side chains | UNIVERSAL DISPLAY CORPORATION (US) | 2015-11-10 | — | — | US | disclosed |
| US-20150207082-A1 | ORGANIC MATERIALS FOR OLEDS | UNIVERSAL DISPLAY CORPORATION (US) | 2015-07-23 | — | — | US | disclosed |
| US-20130293094-A1 | Asymmetric Hosts With Triaryl Silane Side Chains | UNIVERSAL DISPLAY CORPORATION (US) | 2013-11-07 | — | — | US | disclosed |
| US-8513205-B2 | Potent chimeric NRTI-NNRTI bifunctional inhibitors of HIV-1 reverse transcriptase | YALE UNIVERSITY (US) | 2013-08-20 | — | — | US | disclosed |
| US-20110312880-A1 | POTENT CHIMERIC NRTI-NNRTI BIFUNCTIONAL INHIBITORS OF HIV-1 REVERSE TRANSCRIPTASE | ANDERSON KAREN S (US) | 2011-12-22 | — | — | US | disclosed |
| WO-2009126293-A2 | POTENT CHIMERIC NRTI-NNRTI BIFUNCTIONAL INHIBITORS OF HIV-1 REVERSE TRANSCRIPTASE | YALE UNIVERSITY (US) | 2009-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260123185-A1 | PIXEL DEFINE LAYER | EED, PLOD3, VCL | ALDH1A1 4072/4885KDM4E 75/4885SMN1; SMN2 3933/4885 |
| US-20260123278-A1 | COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING THE SAME, AND ELECTRONIC DEVICE THEREOF | SCO2, AOC2, PIEZO1 | ALDH1A1 800/4885KDM4E 1773/4885SMN1; SMN2 1172/4885 |
| US-20110312880-A1 | POTENT CHIMERIC NRTI-NNRTI BIFUNCTIONAL INHIBITORS OF HIV-1 REVERSE TRANSCRIPTASE | NAMPT, NAPRT, DNTT | ALDH1A1 1308/4885KDM4E 2228/4885SMN1; SMN2 2810/4885 |
| US-20150207082-A1 | ORGANIC MATERIALS FOR OLEDS | OCIAD1, OCIAD2, SLC25A21 | ALDH1A1 1012/4885KDM4E 1876/4885SMN1; SMN2 3876/4885 |
| US-20130293094-A1 | Asymmetric Hosts With Triaryl Silane Side Chains | SLC43A1, SLC22A8, SLCO1A2 | ALDH1A1 1790/4885KDM4E 3968/4885SMN1; SMN2 4520/4885 |
| US-12610737-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | ESR2, AR, RER1 | ALDH1A1 848/4885KDM4E 2336/4885SMN1; SMN2 248/4885 |
| US-20260123184-A1 | PIXEL DEFINE LAYER | EED, PLOD3, VCL | ALDH1A1 3560/4885KDM4E 218/4885SMN1; SMN2 3183/4885 |
| US-20260107626-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | SCO2, SOD1, AOC2 | ALDH1A1 1281/4885KDM4E 1217/4885SMN1; SMN2 230/4885 |
| US-20160329502-A1 | Organic Electroluminescent Materials and Devices | OCIAD2, OCIAD1, JUND | ALDH1A1 1283/4885KDM4E 2289/4885SMN1; SMN2 4351/4885 |
| US-12637400-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | EMC1, RER1, EMC2 | ALDH1A1 1510/4885KDM4E 1695/4885SMN1; SMN2 3104/4885 |
| US-20260130109-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | RER1, EMC1, ERLIN1 | ALDH1A1 346/4885KDM4E 845/4885SMN1; SMN2 361/4885 |
| US-20260143922-A1 | ORGANIC LIGHT EMITTING DISPLAY AND ELECTRONIC DEVICE THEREOF | OCIAD2, CD274, ICOSLG | ALDH1A1 1551/4885KDM4E 887/4885SMN1; SMN2 4545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.